Redefining Aging with Next-Gen GLP-1 Therapeutics
We’re pioneering the next generation of longevity-focused drugs that optimize metabolic health to extend healthspan and delay age-related diseases.
Know MoreOur Mission
At Hummsa, we’re focused on the cellular and tissue-level deterioration that underlies many chronic conditions. Our goal is to develop preventive and regenerative therapies that don’t just treat symptoms, but target the biology of decline itself. We combine deep scientific rigor with practical innovation and help people live fuller, healthier lives.
Our Values
We’re building a future where better health is proactive, regenerative, and within reach. By scaling accessible, small molecule therapeutics across borders, we aim to shift the standard of care for degenerative conditions from reactive treatment to real biological repair.
For millions living with diabetes, obesity, fatty liver disease, osteoporosis, and Alzheimer’s, today’s treatments come with limits.
They arrive late, after irreversible damage has begun. They manage symptoms, not the root cause. They rely on lifelong injections, expensive drugs, and cold-chain storage. And they leave patients stuck in maintenance, not recovery.
Our approach starts with science, but it's powered by a larger belief: Better health should be available to everyone and everywhere.
What we do:
Develop therapies that prevent and reverse metabolic dysfunction
Focus on regenerative science to restore long-term health
Design treatments that address multiple conditions in one solution
Leverage oral small-molecule GLP-1 therapies for ease and adherence
Ensure affordability and access through global partnerships
Current partners/funders/investors
We’re just getting started.
Hummsa is growing, in ideas, in partnerships, and in purpose. We’re here to redefine what’s possible in chronic disease care, not by taking incremental steps, but by engineering bold, integrated solutions from the molecular level up.
Join us as we build what comes next.
Contact us
Phone
